Skip to content

Clinical trials

Observational Immune System Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Observational Country / region: United States Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20071
20081
20092
20101
20111
20122
20131
20151
20161
20171
20182
20202
20218
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting12
Active, not recruiting1
Enrolling by invitation1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)7
Yale University3
Columbia University2
Alliance for Clinical Trials in Oncology1
Boston Children's Hospital1
Children's Hospital Medical Center, Cincinnati1
Dragonfly Research, LLC1
EMD Serono1
Erasmus Medical Center1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases36
Autoimmune Diseases11
Nervous System Diseases6
Primary Immunodeficiency Diseases6
Multiple Sclerosis5
Neoplasms5
Autoimmune Diseases of the Nervous System4
Asthma3
COVID-193
Demyelinating Diseases3

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.